INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 134 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2019. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18 | -18.2% | 345 | 0.0% | 0.00% | – |
| Q2 2023 | $22 | +4.8% | 345 | -9.4% | 0.00% | – |
| Q1 2023 | $21 | +5.0% | 381 | 0.0% | 0.00% | – |
| Q4 2022 | $20 | -99.9% | 381 | +8.2% | 0.00% | – |
| Q3 2022 | $16,000 | -20.0% | 352 | 0.0% | 0.00% | – |
| Q2 2022 | $20,000 | +17.6% | 352 | +27.1% | 0.00% | – |
| Q1 2022 | $17,000 | +41.7% | 277 | +16.4% | 0.00% | – |
| Q4 2021 | $12,000 | +20.0% | 238 | -14.7% | 0.00% | – |
| Q3 2021 | $10,000 | +66.7% | 279 | +84.8% | 0.00% | – |
| Q2 2021 | $6,000 | +20.0% | 151 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | 0.0% | 151 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | -44.4% | 151 | -58.5% | 0.00% | – |
| Q3 2020 | $9,000 | +50.0% | 364 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | 0.0% | 364 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | -40.0% | 364 | +20.5% | 0.00% | – |
| Q4 2019 | $10,000 | +400.0% | 302 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -50.0% | 302 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | 0.0% | 302 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 302 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -57.1% | 302 | 0.0% | 0.00% | – |
| Q3 2018 | $7,000 | +40.0% | 302 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | -16.7% | 302 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | – | 302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |